Prevention of Diabetes Mellitus Type 2 in Women Post Gestational Diabetes Mellitus Diagnosis (GDM)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Naomi Meyerstein, Soroka University Medical Center
ClinicalTrials.gov Identifier:
NCT01480895
First received: November 22, 2011
Last updated: November 28, 2011
Last verified: November 2011
  Purpose

Diabetes Mellitus (DM) is a chronic metabolic disorder with increasing incidence and long term complications. Its incidence differs in various ethnic populations.Gestational DM (GDM) is diagnosed when impaired glucose tolerance (IGT) is first detected during pregnancy. GDM incidence in Jewish and Bedouin women has been rising in recent years. It has been reported in many studies that women who had been diagnosed with GDM are more prone to GDM in their next pregnancies and to DM Type 2.

Appropriate changes in everyday diet and physical exercise may reduce the chances for future GDM and type 2 DM.

The investigators aim was to determine GDM frequency in the Negev area in Jewish and Bedouin populations and to construct a plan for follow up and reduce future problems by changing their life style.


Condition Intervention
Gestational Diabetes Mellitus
Behavioral: Lifestyle instruction for Jews and Bedouin GDM women.

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Identification of Risk Factors for DM Type 2 in Women Post GDM Diagnosis and Its Prevention by Changing Life Style

Resource links provided by NLM:


Further study details as provided by Soroka University Medical Center:

Primary Outcome Measures:
  • Change in HOMA ratios (Homeostasis Model Assessments of Insulin Resistance). [ Time Frame: Determination of HOMA after one year. ] [ Designated as safety issue: No ]
    The metabolic parameters included glucose and insulin levels, to enable calculations of HOMA IR. (Homeostasis Model Assessment of Insulin Resistance).

  • Change in HOMA. [ Time Frame: Detrmination of HOMA after two years. ] [ Designated as safety issue: No ]
    HOMA calculations post partum.


Secondary Outcome Measures:
  • Determinations of blood lipids . [ Time Frame: Post partum lipids levels after one year. ] [ Designated as safety issue: No ]
    Determinations of total lipids , total cholesterol , HDL, LDL and triglycerides levels.

  • Change in lipids levels after two years post partum. [ Time Frame: 2 years after delivery. ] [ Designated as safety issue: No ]
    Determinations of total cholesterol, HDL,LDL,and triglycerides after one year.

  • Post partum BMI changes. [ Time Frame: one year after delivery. ] [ Designated as safety issue: No ]
    BMI assessments after one year.

  • BMI changes after delivery. [ Time Frame: Two years after delivery. ] [ Designated as safety issue: No ]
    BMI assessments after delivery.


Enrollment: 180
Study Start Date: March 2007
Study Completion Date: April 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Post GDM follow-up group. Behavioral: Lifestyle instruction for Jews and Bedouin GDM women.
Every several months the women had instructions and checkups.
Other Name: Jew and Bedouin women with recent GDM in the Negev area.
Experimental: lifestyle intervention group.
The women in this group had participated in lifestyle intervention by diet instructions and physical exercise program.
Behavioral: Lifestyle instruction for Jews and Bedouin GDM women.
Every several months the women had instructions and checkups.
Other Name: Jew and Bedouin women with recent GDM in the Negev area.

Detailed Description:

Diabetes Mellitus is a very common chronic metabolic disorder,currently an epidemic with correlation to obesity. DM frequency differs as a function of population characteristics factors. In Israel it is more prevalent in Jews than in Bedouins. However, lately, there has been a rise in DM frequency in the Bedouin population. This rise is probably due to the change in life style from the traditional way of life towards a western one, characterized by change in food habits and decrease in physical activity. This combination may lead to increased body mass index (BMI)and to DM.

Many studies report higher incidence of DM type 2 following Gestational Diabetes Mellitus (GDM). GDM is defined as glucose intolerance which is detected during pregnancy in healthy women. Its frequency varies between 1 to 14% in pregnant women in different populations. Although usually glucose intolerance disappears after delivery,many of these women may develop future GMD or DM type 2. This can be delayed or even prevented by appropriate diet and increased physical activity.

The aim of our study was:

  1. To determine GDM frequency in Jewish and Bedouin populations in the Negev area in southern Israel.
  2. To approach Jewish and Bedouin GDM women before discharge from the hospital and invite them to join the study and divide them into intervention group and control respectively.
  3. To study whether intervention in life style leads to similar results in both populations.
  4. To propose a model for predicting persistent lifestyle change intervention.

The study included 180 women diagnosed with GDM ,133 Jewish and 47 Bedouin women.The women were divided in two groups, an intervention group (77 Jewish and 26 Bedouin) and control ones (56 Jewish and 21 Bedouin women). At their first visit, 3 months after delivery all women filled forms about demographic data, nutrition and physical habits. All of them, including the control group were given full information about GDM and increased risk for DM.

All the women signed their informed consent forms for participation in the study. The intervention group had several group meetings every several months. Metabolic parameters were determined, including plasma insulin ,glucose and lipids levels.Height, weight, BMI, blood pressure and abdominal circumference were measured too. The same parameters were determined one and two years post partum. The intervention group had several group meetings every several months with a dietician and a physical exercise instructor.

  Eligibility

Ages Eligible for Study:   18 Years to 43 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Diagnosis of gestational diabetes.

Exclusion Criteria:

  • Diabetes Mellitus
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Naomi Meyerstein, Dr Naomi Meyerstein M D, Soroka University Medical Center
ClinicalTrials.gov Identifier: NCT01480895     History of Changes
Other Study ID Numbers: SOR452307CTL
Study First Received: November 22, 2011
Last Updated: November 28, 2011
Health Authority: Israel: Ministry of Health

Keywords provided by Soroka University Medical Center:
Diabetes Mellitus Type 2
Gestational Diabetes Mellitus
Glucose Intolerance
Physical exercise
Nutritional Habits
Dyslipidemia

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes, Gestational
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications

ClinicalTrials.gov processed this record on September 22, 2014